Board of Directors

Timothy Chen

Director

  • Corporate Vice President of Hon Hai Technology Group and President of Asia Pacific Telecom since January 2016.
  • Chairman of the board of Autohome Inc. since 2012.
  • Former President of Telstra International Group
  • Former partner of GL Capital Group
  • Former CEO of National Basketball Association China
  • Former Corporate Vice President of Microsoft and CEO of its Greater China region
  • Former Corporate Vice President of Motorola and the Chairman and President of Motorola (China) Electronics
  • MBA from University of Chicago, a master’s degree in both computer science and mathematics from Ohio State University

Donald W. Glazer

Director

  • Member of board of directors since February 2013
  • Member of the Board of Trustees of GMO Trust since 2000, Chairman of GMO’s Board since 2005
  • Advisory Counsel to Goodwin Procter LLP since 1997
  • Co-Founder and Secretary at Provant, Inc., and Vice Chairman (2002-2010)
  • President of Mugar/Glazer Holdings (1992-1995)
  • Partner at Ropes & Gray LLP, chaired the Emerging Companies Group (1978-1999)
  • Vice Chairman-Finance, New England Television Corp. and WHDH-TV (1992-1993)
  • Lecturer in Law at Harvard Law School from 1978 to 1991, taught course called The Business Lawyer
  • Former member of the boards of directors of Environics Inc., Kronos Incorporated, Reflective Technologies, Inc. and Teleco Oilfield Services Inc.
  • Received A.B. from Dartmouth College; J.D. from Harvard Law School, where he was editor of the Harvard Law Review; and L.L.M. from the University of Pennsylvania Law School
  • Co-author of both Glazer and FitzGibbon on Legal Opinions, Third Edition (Aspen Publishers) and Massachusetts Corporation Law & Practice, Second Edition (Aspen Publishers)

Michael Goller

Director

  • Member of board of directors since April 2015
  • Joined Baker Bros. Advisors LP in 2005, currently serves as Managing Director
  • Former Associate at JPMorgan Partners, where he focused on venture investments in life sciences sector from 1999-2003
  • Began career as investment banker at Merrill Lynch and Co. from 1997-1999
  • B.S. in Molecular and Cell Biology from Pennsylvania State University and Masters degrees in Biotechnology (School of Engineered and Applied Sciences) and Business Administration (Wharton School) from the University of Pennsylvania

Ranjeev Krishana

Director

  • Member of board of directors since October 2014
  • At Baker Bros. Advisors LP since 2011 and currently serves as its Head of International Investments
  • Formerly held commercial, strategy, and business development leadership roles at Pfizer’s pharmaceutical business in international regions and markets, including Asia, Eastern Europe, and Latin America
  • Senior Director and member of Pfizer China Leadership Team in Beijing
  • Began career as a strategy consultant at Accenture
  • B.A. in Economics and Political Science from Brown University, and  Masters of Public Policy from Harvard University

Thomas Malley

Director

  • President of Mossrock Capital, a private investment firm in Denver, Colorado, since 2007
  • Member in Board of Directors at Kura Oncology and Ovascience, both of which are publicly traded biotech firms
  • Former member in Board of Directors at SynagevaBiopharma and Puma Biotechnology, which were publicly traded biotech companies
  • Former portfolio manager of the Janus Global Life Sciences Fund, Former Vice President of Janus Healthcare
  • Former Equity analyst for Janus covering healthcare and biotechnology, telecommunications, gaming and lodging, and housing stocks
  • Former board of directors of Cougar Biotechnology, prior to its acquisition by Johnson and Johnson
  • B.S. in Biology from Stanford University

John V. Oyler

Chairman, Founder & CEO

  • Has served as CEO and Director since founding BeiGene in 2010
  • Founder & CEO of BioDuro, 700-person integrated research CRO in Beijing, sold to Pharmaceutical Product Development Inc. with attractive returns (2005-2009)
  • CEO of Galenea, Boston biotech started from MIT with funding from Otsuka, (2002-2004)
  • Founder, President of Telephia, sold to Nielsen (1997-2002)
  • Co-CEO of Genta (GNTA), publicly-traded oncology company that grew in late ’90s to $1.7 billion in revenues (1997-1998)
  • Began career at McKinsey & Company
  • MBA from Stanford University
  • B.S. from Massachusetts Institute of Technology

Xiaodong Wang, Ph.D.

Director, Founder & Chairman of Scientific Advisory Board

  • Founded BeiGene in 2010, and has served as Chairman of Scientific Advisory Board since 2011
  • Founding Director & Architect of 700-person team at the National Institute of Biological Sciences (NIBS) in Beijing (2003-present)
  • Howard Hughes Medical Institute Investigator, George L. MacGregor Distinguished Chair in Biomedical Sciences (1997-2010) and Professor in Biomedical Sciences (2001-2010) at University of Texas Southwestern Medical Center
  • Member of National Academy of Sciences, USA
  • Foreign associate of Chinese Academy of Sciences
  • Founder of Joyant Pharmaceuticals, venture capital-backed oncology biotech in US
  • Ph.D. in Biochemistry from University of Texas Southwestern Medical Center
  • B.S. in Biology from Beijing Normal University

Michael Qingqing Yi

Director

  • Member of board of directors since October 2014
  • Principal at Hillhouse Capital Group since inception of the firm in 2005
  • Former Equity Research Analyst at China International Capital Corporation
  • B.S. in Engineering from Shanghai Maritime University
  • M.B.A. from University of Southern California